In VivoDifferentiation of Mast Cells from Acute Myeloid Leukemia Blasts Carrying a Novel Activating Ligand-Independent C-kit Mutation
- 1 June 1998
- journal article
- case report
- Published by Elsevier BV in Blood Cells, Molecules, and Diseases
- Vol. 24 (2), 262-270
- https://doi.org/10.1006/bcmd.1998.0191
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomasNature Genetics, 1997
- A new c‐kit mutation in a case of aggressive mast cell diseaseBritish Journal of Haematology, 1997
- Role of c‐kit receptor tyrosine kinase in the development, survival and neoplastic transformation of mast cellsPathology International, 1996
- Genetic analysis reveals cell type-specific regulation of receptor tyrosine kinase c-Kit by the protein tyrosine phosphatase SHP1.The Journal of Experimental Medicine, 1996
- Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasmNature Genetics, 1996
- c-kit point mutation of extracellular domain in patients with myeloproliferative disordersBritish Journal of Haematology, 1995
- Substitution of an Aspartic Acid Results in Constitutive Activation of c-kitReceptor Tyrosine Kinase in a Rat Tumor Mast Cell Line RBL-2H3International Archives of Allergy and Immunology, 1995
- Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product.JCI Insight, 1993
- Signal transduction by receptors with tyrosine kinase activityCell, 1990
- GROWTH FACTOR RECEPTOR TYROSINE KINASESAnnual Review of Biochemistry, 1988